Account
Inquiry
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist currently being developed for type 2 diabetes treatment and weight management applications. Our factory supplies high-quality tirzepatide at competitive prices for research purposes.
Clinical studies have demonstrated tirzepatide's superior efficacy in glucose control and weight reduction compared to selective GLP-1 receptor agonists. In the SURMOUNT-1 trial, participants achieved average weight loss of 15-20.9% after 72 weeks of treatment, depending on dosage.
The peptide features a modified lysine side chain with PEGylation, enhancing water solubility while maintaining biological activity. This innovative structure allows tirzepatide to effectively mimic natural GIP actions at the GIP receptor while also activating GLP-1 receptors.
Our pharmaceutical-grade tirzepatide is supplied as a white powder with purity exceeding 99.9%. The product is carefully packaged to ensure stability and longevity, with options available for custom packaging requirements.
For research applications, proper storage is essential: maintain in a cool, dry, dark environment; avoid repeated freeze-thaw cycles; minimize air exposure; and aliquot according to experimental needs.
Note: This product is intended for research use only, not for human consumption. Researchers should handle all peptides with appropriate safety precautions.
